Structure of influenza virus N7: The last piece of the neuraminidase "Jigsaw" puzzle

Journal of Virology

Volumn 88, Issue 16, 2014, Pages 9197-9207

  Sun, Xiaoman ^a,b   Li, Qing ^a,c   Wu, Yan ^a   Wang, Mingyang ^a   Liu, Yue ^a   Qi, Jianxun ^a   Vavricka, Christopher J ^a,d   Gao, George F ^a,b,d,e  

^a INSTITUTE OF MICROBIOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c UNIVERSITY OF SCIENCE AND TECHNOLOGY OF CHINA   (China)

^d INSTITUTE OF GEOLOGY AND GEOPHYSICS   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

NEURAMINIDASE N6; NEURAMINIDASE N7; SIALIC ACID; UNCLASSIFIED DRUG; VIRUS SIALIDASE;

ARTICLE; BINDING SITE; CALCIUM BINDING; COMPARATIVE STUDY; ENZYME ACTIVE SITE; ENZYME CONFORMATION; ENZYME GLYCOSYLATION; ENZYME STRUCTURE; INFLUENZA VIRUS; NONHUMAN; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

CALCIUM; CATALYTIC DOMAIN; GLYCOSYLATION; N-ACETYLNEURAMINIC ACID; NEURAMINIDASE; ORTHOMYXOVIRIDAE; PROTEIN CONFORMATION; VIRAL PROTEINS;

EID: 84904911888     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.00805-14     Document Type: Article

References (45)

1. Medina RA, Garcia-Sastre A. 2011. Influenza A viruses: new research developments. Nat. Rev. Microbiol. 9:590-603. http://dx.doi.org/10.1038/nrmicro2613.
2. Dawood FS, Jain S, Finelli L, Shaw MW, Lindstrom S, Garten RJ, Gubareva LV, Xu X, Bridges CB, Uyeki TM. 2009. Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N. Engl. J. Med. 360: 2605-2615. http://dx.doi.org/10.1056/NEJMoa0903810.
3. Neumann G, Noda T, Kawaoka Y. 2009. Emergence and pandemic potential of swine-origin H1N1 influenza virus. Nature 459:931-939. http://dx.doi.org/10.1038/nature08157.
4. Liu D, Shi W, Shi Y, Wang D, Xiao H, Li W, Bi Y, Wu Y, Li X, Yan J, Liu W, Zhao G, Yang W, Wang Y, Ma J, Shu Y, Lei F, Gao GF. 2013. Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses. Lancet 381:1926-1932. http://dx.doi.org/10.1016/S0140-6736(13)60938-1.
5. Lang G, Gagnon A, Geraci JR. 1981. Isolation of an influenza A virus from seals. Arch. Virol. 68:189-195. http://dx.doi.org/10.1007/BF01314571.
6. Banks J, Speidel E, Alexander DJ. 1998. Characterisation of an avian influenza A virus isolated from a human-is an intermediate host necessary for the emergence of pandemic influenza viruses? Arch. Virol. 143: 781-787. http://dx.doi.org/10.1007/s007050050329.
7. Shinya K, Watanabe S, Ito T, Kasai N, Kawaoka Y. 2007. Adaptation of an H7N7 equine influenza A virus in mice. J. Gen. Virol. 88:547-553. http://dx.doi.org/10.1099/vir.0.82411-0.
8. Min JY, Vogel L, Matsuoka Y, Lu B, Swayne D, Jin H, Kemble G, Subbarao K. 2010. A live attenuated H7N7 candidate vaccine virus induces neutralizing antibody that confers protection from challenge in mice, ferrets, and monkeys. J. Virol. 84:11950-11960. http://dx.doi.org/10.1128/JVI.01305-10.
9. Du Ry van Beest Holle M, Meijer A, Koopmans M, de Jager CM. 2005. Human-to-human transmission of avian influenza A/H7N7, The Netherlands, 2003. Euro Surveill. 10:264-268. http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=584.
10. Gibbens N. 2008. Avian influenza outbreak in Oxfordshire. Vet. Rec. 162:795. http://dx.doi.org/10.1136/vr.162.24.795.
11. Lam TT, Wang J, Shen Y, Zhou B, Duan L, Cheung CL, Ma C, Lycett SJ, Leung CY, Chen X, Li L, Hong W, Chai Y, Zhou L, Liang H, Ou Z, Liu Y, Farooqui A, Kelvin DJ, Poon LL, Smith DK, Pybus OG, Leung GM, Shu Y, Webster RG, Webby RJ, Peiris JS, Rambaut A, Zhu H, Guan Y. 2013. The genesis and source of the H7N9 influenza viruses causing human infections in China. Nature 502:241-244. http://dx.doi.org/10.1038/nature12515.
12. Skehel JJ, Wiley DC. 2000. Receptor binding and membrane fusion in virus entry: the influenza hemagglutinin. Annu. Rev. Biochem. 69:531-569. http://dx.doi.org/10.1146/annurev.biochem.69.1.531.
13. Colman PM. 1994. Influenza virus neuraminidase: structure, antibodies, and inhibitors. Protein Sci. 3:1687-1696. http://dx.doi.org/10.1002/pro.5560031007.
14. Wu Y, Wu Y, Tefsen B, Shi Y, Gao GF. 2014. Bat-derived influenza-like viruses H17N10 and H18N11. Trends Microbiol. 22:183-191. http://dx.doi.org/10.1016/j.tim.2014.01.010.
15. Air GM. 2012. Influenza neuraminidase. Influenza Other Respir. Viruses 6:245-256. http://dx.doi.org/10.1111/j.1750-2659.2011.00304.x.
16. Air GM, Laver WG. 1989. The neuraminidase of influenza virus. Proteins 6:341-356. http://dx.doi.org/10.1002/prot.340060402.
17. von Itzstein M. 2007. The war against influenza: discovery and development of sialidase inhibitors. Nat. Rev. Drug Discov. 6:967-974. http://dx.doi.org/10.1038/nrd2400.
18. von Itzstein M. 2012. Influenza virus sialidase: a drug discovery target. Springer, Basel, Switzerland.
19. Kim CU, Lew W, Williams MA, Liu H, Zhang L, Swaminathan S, Bischofberger N, Chen MS, Mendel DB, Tai CY, Laver WG, Stevens RC. 1997. Influenza neuraminidase inhibitors possessing a novel hydrophobic interaction in the enzyme active site: design, synthesis, and structural analysis of carbocyclic sialic acid analogues with potent antiinfluenza activity. J. Am. Chem. Soc. 119:681-690. http://dx.doi.org/10.1021/ja963036t.
20. Russell RJ, Haire LF, Stevens DJ, Collins PJ, Lin YP, Blackburn GM, Hay AJ, Gamblin SJ, Skehel JJ. 2006. The structure of H5N1 avian influenza neuraminidase suggests new opportunities for drug design. Nature 443:45-49. http://dx.doi.org/10.1038/nature05114.
21. Xu X, Zhu X, Dwek RA, Stevens J, Wilson IA. 2008. Structural characterization of the 1918 influenza virus H1N1 neuraminidase. J. Virol. 82: 10493-10501. http://dx.doi.org/10.1128/JVI.00959-08.
22. Rudrawar S, Dyason JC, Rameix-Welti MA, Rose FJ, Kerry PS, Russell RJ, van der Werf S, Thomson RJ, Naffakh N, von Itzstein M. 2010. Novel sialic acid derivatives lock open the 150-loop of an influenza A virus group-1 sialidase. Nat. Commun. 1:113. http://dx.doi.org/10.1038/ncomms1114.
23. Li Q, Qi J, Zhang W, Vavricka CJ, Shi Y, Wei J, Feng E, Shen J, Chen J, Liu D, He J, Yan J, Liu H, Jiang H, Teng M, Li X, Gao GF. 2010. The 2009 pandemic H1N1 neuraminidase N1 lacks the 150-cavity in its active site. Nat. Struct. Mol. Biol. 17:1266-1268. http://dx.doi.org/10.1038/nsmb.1909.
24. Wu Y, Qin G, Gao F, Liu Y, Vavricka CJ, Qi J, Jiang H, Yu K, Gao GF. 2013. Induced opening of influenza virus neuraminidase N2 150-loop suggests an important role in inhibitor binding. Sci. Rep. 3:1551. http://dx.doi.org/10.1038/srep01551.
25. van der Vries E, Collins PJ, Vachieri SG, Xiong X, Liu J, Walker PA, Haire LF, Hay AJ, Schutten M, Osterhaus AD, Martin SR, Boucher CA, Skehel JJ, Gamblin SJ. 2012. H1N1 2009 pandemic influenza virus: resistance of the I223R neuraminidase mutant explained by kinetic and structural analysis. PLoS Pathog. 8:e1002914. http://dx.doi.org/10.1371/journal.ppat.1002914.
26. Mohan S, McAtamney S, Haselhorst T, von Itzstein M, Pinto BM. 2010. Carbocycles related to oseltamivir as influenza virus group-1-specific neuraminidase inhibitors. Binding to N1 enzymes in the context of viruslike particles. J. Med. Chem. 53:7377-7391. http://dx.doi.org/10.1021/jm100822f.
27. Wu Y, Bi Y, Vavricka CJ, Sun X, Zhang Y, Gao F, Zhao M, Xiao H, Qin C, He J, Liu W, Yan J, Qi J, Gao GF. 2013. Characterization of two distinct neuraminidases from avian-origin human-infecting H7N9 influenza viruses. Cell Res. 23:1347-1355. http://dx.doi.org/10.1038/cr.2013.144.
28. Vavricka CJ, Liu Y, Kiyota H, Sriwilaijaroen N, Qi J, Tanaka K, Wu Y, Li Q, Li Y, Yan J, Suzuki Y, Gao GF. 2013. Influenza neuraminidase operates via a nucleophilic mechanism and can be targeted by covalent inhibitors. Nat. Commun. 4:1491. http://dx.doi.org/10.1038/ncomms2487.
29. Wang M, Qi J, Liu Y, Vavricka CJ, Wu Y, Li Q, Gao GF. 2011. Influenza A virus N5 neuraminidase has an extended 150-cavity. J. Virol. 85:8431-8435. http://dx.doi.org/10.1128/JVI.00638-11.
30. Otwinowski Z, Minor W. 1997. Processing of X-ray diffraction data collected in oscillation mode. Methods Enzymol. 276:307-326. http://dx.doi.org/10.1016/S0076-6879(97)76066-X.
31. Read RJ. 2001. Pushing the boundaries of molecular replacement with maximum likelihood. Acta Crystallogr.DBiol. Crystallogr. 57:1373-1382. http://dx.doi.org/10.1107/S0907444901012471.
32. Murshudov GN, Vagin AA, Dodson EJ. 1997. Refinement of macromolecular structures by the maximum-likelihood method. Acta Crystallogr.DBiol. Crystallogr. 53:240-255. http://dx.doi.org/10.1107/S0907444996012255.
33. Emsley P, Cowtan K. 2004. Coot: model-building tools for molecular graphics. Acta Crystallogr. D Biol. Crystallogr. 60:2126-2132. http://dx.doi.org/10.1107/S0907444904019158.
34. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, McCoy AJ, Moriarty NW, Oeffner R, Read RJ, Richardson DC, Richardson JS, Terwilliger TC, Zwart PH. 2010. PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66: 213-221. http://dx.doi.org/10.1107/S0907444909052925.
35. Laskowski RA, Macarthur MW, Moss DS, Thornton JM. 1993. Procheck: a program to check the stereochemical quality of protein structures. J. Appl. Crystallogr. 26:283-291. http://dx.doi.org/10.1107/S0021889892009944.
36. Potier M, Mameli L, Belisle M, Dallaire L, Melancon SB. 1979. Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferylalpha-D-N-acetylneuraminate) substrate. Anal. Biochem. 94:287-296. http://dx.doi.org/10.1016/0003-2697(79)90362-2.
37. Li Q, Sun X, Li Z, Liu Y, Vavricka CJ, Qi J, Gao GF. 2012. Structural and functional characterization of neuraminidase-like molecule N10 derived from bat influenza A virus. Proc. Natl. Acad. Sci. U. S. A. 109:18897-18902. http://dx.doi.org/10.1073/pnas.1211037109.
38. Rudino PE, Tunnah P, Crennell SJ, Webster RG, Laver WG, Garman EF. 2006. The crystal structure of type A influenza virus neuraminidase subtype N6 reveals the existence of two separate Neu5Ac binding sites. PDB IDs: 1W1X, 1V0Z,1W20, 1W21, 2CML. http://www.rcsb.org/pdb/explore/explore.do?structureId=1W1X.
39. Li Q, Qi J, Wu Y, Kiyota H, Tanaka K, Suhara Y, Ohrui H, Suzuki Y, Vavricka CJ, Gao GF. 2013. Functional and structural analysis of influenza virus neuraminidase N3 offers further insight into the mechanisms of oseltamivir resistance. J. Virol. 87:10016-10024. http://dx.doi.org/10.1128/JVI.01129-13.
40. Vavricka CJ, Li Q, Wu Y, Qi J, Wang M, Liu Y, Gao F, Liu J, Feng E, He J, Wang J, Liu H, Jiang H, Gao GF. 2011. Structural and functional analysis of laninamivir and its octanoate prodrug reveals group specific mechanisms for influenza NA inhibition. PLoS Pathog. 7:e1002249. http://dx.doi.org/10.1371/journal.ppat.1002249.
41. Tong S, Zhu X, Li Y, Shi M, Zhang J, Bourgeois M, Yang H, Chen X, Recuenco S, Gomez J, Chen L-M, Johnson A, Tao Y, Dreyfus C, Yu W, McBride R, Carney PJ, Gilbert AT, Chang J, Guo Z, Davis CT, Paulson JC, Stevens J, Rupprecht CE, Holmes EC, Wilson IA, Donis RO. 2013. New World bats harbor diverse influenza A viruses. PLoS Pathog. 9:e1003657. http://dx.doi.org/10.1371/journal.ppat.1003657.
42. Lawrenz M, Wereszczynski J, Amaro R, Walker R, Roitberg A, Mc-Cammon JA. 2010. Impact of calcium on N1 influenza neuraminidase dynamics and binding free energy. Proteins 78:2523-2532.
43. Smith BJ, Huyton T, Joosten RP, McKimm-Breschkin JL, Zhang JG, Luo CS, Lou MZ, Labrou NE, Garrett TP. 2006. Structure of a calciumdeficient form of influenza virus neuraminidase: implications for substrate binding. Acta Crystallogr.DBiol. Crystallogr. 62:947-952. http://dx.doi.org/10.1107/S0907444906020063.
44. Sung JC, Van Wynsberghe AW, Amaro RE, Li WW, McCammon JA. 2010. Role of secondary sialic acid binding sites in influenza N1 neuraminidase. J. Am. Chem. Soc. 132:2883-2885. http://dx.doi.org/10.1021/ja9073672.
45. Varghese JN, Colman PM, van Donkelaar A, Blick TJ, Sahasrabudhe A, McKimm-Breschkin JL. 1997. Structural evidence for a second sialic acid binding site in avian influenza virus neuraminidases. Proc. Natl. Acad. Sci. U. S. A. 94:11808-11812. http://dx.doi.org/10.1073/pnas.94.22.11808.